Owner and Principal
Bioanalytical Solution Integration
Westampton, New Jersey
Mark E. Arnold, Ph.D. is Owner and Principal of Bioanalytical Solution Integration; consulting with biotech and pharma companies to advance their portfolios to bring new therapies to patients in need. In that role, he collaboratively develops the bioanalytical scientific and regulatory strategy to meet current and future client needs. Mark was previously Executive Director of the Bioanalytical Sciences Department at Bristol-Myers Squibb Co. and Director of Science for the Scientific Affairs Department at Labcorp supporting bioanalytical and clinical laboratories. He received a B.S. in biology from Indiana University of Pennsylvania and a Ph.D. in pharmacology from the University of Pittsburgh. For 40 years, Dr. Arnold has been involved in the application of bioanalysis to developing new therapies, including the review and interpretation of regulations and guidance as they apply to the evolving science in bioanalytical and clinical laboratories. He was co-chair of both the AAPS-FDA Crystal City V and VI Workshops and has been a member of the AAPS since 1988 holding a variety of committee positions including 2023-2024 Scientific Advisory Chair, 2022 PharmSci360 Scientific Program Committee Chair, 2018 PharmSci360 Bioanalytical Track Chair and is AAPS Fellow (2014). Dr. Arnold has over 115 peer-reviewed publications and numerous invited podium presentations.
Disclosure information not submitted.
Keynote: Reflections on Transformations in Drug Development, Bioanalysis and Regulations
Monday, November 10, 2025
1:30 PM - 2:30 PM CT